PURPOSE: To examine the role of systemic activation of the complement system (assessed by levels of circulating C3a, Ba, and sC5b-9) in patients (n = 122) with advanced age-related macular degeneration, geographic atrophy, and neovascular age-related macular degeneration, compared with cataract controls (n = 27). METHODS: Plasma complement factors were measured using enzyme-linked immunosorbent assays. Statistical analysis included univariate and multivariate logistic regression (p < 0.05). RESULTS: Adjusted for age, the odds ratios of C3a and sC5b-9 for any advanced age-related macular degeneration were 1.78 (95% confidence interval = 1.16-2.73, p < 0.01) and 1.20 (95% confidence interval = 1.04-1.39, p = 0.01), respectively. We found a significantly elevated adjusted odds ratio of C3a (adjusted odds ratio = 1.71, 95% confidence interval = 1.12-2.60, p = 0.01) and sC5b-9 (adjusted odds ratio = 1.22, 95% confidence interval = 1.04-1.43, p = 0.01) for neovascular age-related macular degeneration. Adjusted for age, neither C3a, sC5b-9, nor Ba were associated with geographic atrophy. CONCLUSION: We suggest a role for elevated plasma levels of C3a and sC5b-9 in patients with neovascular age-related macular degeneration. The study's results reinforce the need for more investigation to assess the impact of therapeutic interventions targeted at the complement signaling pathways in age-related macular degeneration.
PURPOSE: To examine the role of systemic activation of the complement system (assessed by levels of circulating C3a, Ba, and sC5b-9) in patients (n = 122) with advanced age-related macular degeneration, geographic atrophy, and neovascular age-related macular degeneration, compared with cataract controls (n = 27). METHODS: Plasma complement factors were measured using enzyme-linked immunosorbent assays. Statistical analysis included univariate and multivariate logistic regression (p < 0.05). RESULTS: Adjusted for age, the odds ratios of C3a and sC5b-9 for any advanced age-related macular degeneration were 1.78 (95% confidence interval = 1.16-2.73, p < 0.01) and 1.20 (95% confidence interval = 1.04-1.39, p = 0.01), respectively. We found a significantly elevated adjusted odds ratio of C3a (adjusted odds ratio = 1.71, 95% confidence interval = 1.12-2.60, p = 0.01) and sC5b-9 (adjusted odds ratio = 1.22, 95% confidence interval = 1.04-1.43, p = 0.01) for neovascular age-related macular degeneration. Adjusted for age, neither C3a, sC5b-9, nor Ba were associated with geographic atrophy. CONCLUSION: We suggest a role for elevated plasma levels of C3a and sC5b-9 in patients with neovascular age-related macular degeneration. The study's results reinforce the need for more investigation to assess the impact of therapeutic interventions targeted at the complement signaling pathways in age-related macular degeneration.
Authors: Nathaniel Gelinas; Anne M Lynch; Marc T Mathias; Alan G Palestine; Naresh Mandava; Karen L Christopher; Jennifer L Patnaik Journal: Int J Ophthalmol Date: 2022-03-18 Impact factor: 1.779
Authors: Brandie D Wagner; Jennifer L Patnaik; Alan G Palestine; Ashley A Frazer-Abel; Rebecca Baldermann; V Michael Holers; Marc T Mathias; Naresh Mandava; Anne M Lynch Journal: Ophthalmic Epidemiol Date: 2021-04-08
Authors: Anne M Lynch; Alan G Palestine; Brandie D Wagner; Jennifer L Patnaik; Ashley A Frazier-Abel; Marc T Mathias; Frank S Siringo; Vernon Michael Holers; Naresh Mandava Journal: BMJ Open Ophthalmol Date: 2020-01-14
Authors: Cheryl N Fonteh; Alan G Palestine; Brandie D Wagner; Jennifer L Patnaik; Marc T Mathias; Naresh Mandava; Rebecca Baldermann; Anne M Lynch Journal: Transl Vis Sci Technol Date: 2022-02-01 Impact factor: 3.283
Authors: Rachel C Chen; Alan G Palestine; Anne M Lynch; Jennifer L Patnaik; Brandie D Wagner; Marc T Mathias; Naresh Mandava Journal: Transl Vis Sci Technol Date: 2021-10-04 Impact factor: 3.283
Authors: Nikhil Mandava; Vanessa Tirado-Gonzalez; Matthew D Geiger; Jennifer L Patnaik; Ashley Frazer-Abel; Anne M Lynch; Naresh Mandava; Alan G Palestine; V Michael Holers; Brandie D Wagner; Idaira Sanchez-Santos; Daniela Meizner; Hugo Quiroz-Mercado; Jesse M Smith Journal: Invest Ophthalmol Vis Sci Date: 2020-09-01 Impact factor: 4.799
Authors: Anne M Lynch; Brandie D Wagner; Alan G Palestine; Nebojsa Janjic; Jennifer L Patnaik; Marc T Mathias; Frank S Siringo; Naresh Mandava Journal: Transl Vis Sci Technol Date: 2020-09-11 Impact factor: 3.283